<DOC>
	<DOCNO>NCT01630551</DOCNO>
	<brief_summary>Ocular surface disease ( OSD ) significant health problem affect 10 million person United States alone . OSD highly prevalent among medically treat patient glaucoma associate number intraocular pressure ( IOP ) -lowering medication use . The purpose study determine potential effectiveness anoritega-3 fatty acid nutritional supplement treatment ocular surface disease associate '' use glaucoma eye drop</brief_summary>
	<brief_title>Omega 3 Supplementation Ocular Surface Disease Glaucoma</brief_title>
	<detailed_description>Description procedures/methods : BASELINE VISIT Once treat ophthalmologist make diagnosis OSD , subject ask participate research study . Informed consent obtain subject willing participate study . Afterwards , treat ophthalmologist administer dry eye questionnaire subject . After completion questionnaire , subject give 90-day supply study drug/placebo . Based pre-determined randomization list , subject randomize receive either study medication ( TheraTears nutritional supplementation ) placebo drug ( olive oil capsule ) . All subject instruct continue use artificial lubrication need take part study . We hypothesize therapy oral fish oil nutritional supplement contain 450mg EPA , 300 mg DHA , 1000 mg flaxseed oil ( TheraTears Nutrition ; Advanced Vision Research , Woburn , MA ) decrease OSD-related symptom well clinical marker associate OSD ( Schirmer test value , positive vital stain lissamine green , fluorescein tear break-up time , tear film osmolarity ) compare administration placebo . FOLLOW-UP VISIT Approximately 90 day baseline visit , subject schedule come clinic routineâ€¢ eye check . At visit , subject 's O.SD re-assessed examination technique baseline visit . After examination , questionnaire administer second time . The study drug discontinue visit standard therapy subject 's OSO , deem necessary treating ophthalmologist , institute . Statement duration subject participation : Subject study 3 month . There two visit , one baseline second follow-up visit . All visit coincide regular clinic visit . The total hour study participation 2 hour .</detailed_description>
	<criteria>Age &gt; 18 year Typical symptom dry eye ( photophobia , burning , foreign body sensation , blur vision improve blinking ) OSDI score &gt; 12 Schirmer Test Anesthesia &lt; 8 mm/5 minute Fluorescein tear breakup time &lt; 8 second No current use dry eye treatment ( except artificial lubrication ) Infectious keratoconjunctivitis inflammatory disease unrelated dry eye topical glaucoma medication use Patients severe tear deficiency ( defined Schirmer te &lt; 5 mm/5 min ) Concomitant ocular pathology History ocular surgery Eyelid eyelash abnormality Alteration nasolacrimal apparatus Treatment drug affect tear Treatment vitamin supplement Concomitant ocular therapy Topical ophthalmic steroid take 4 week study Pregnant/breastfeeding woman Women may pregnant baseline visit may become pregnant 90 day therapy Diabetes History fish and/or shellfish allergy hypersensitivity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>tear</keyword>
	<keyword>dry eye</keyword>
	<keyword>ocular surface disease</keyword>
</DOC>